Investor Relations

Press, quotes, SEC filings, alerts, more.


Candidates for COVID-19 clinical trials.


SIP© cancer treatment information.

EdgePoint AI

Core cloud-computer AI platform.

Most recent news and events

Oncotelic Happenings

Oncotelic presents at the 3rd Meridian Clinical Trials

On November 3, 2020, Dr. Vuong Trieu, CEO of Oncotelic, presented at the 3rd Meridian Clinical Trials, in San Francisco about COVID-19 trials in the current hyper-competitive environment. Learn more >

11 Billion $

target markets

100 Plus

patent applications

2 Key

clinical programs

30 Years


Questions or Comments?

Copyright © 2020 Onteclic Therapeutics Inc., a TGF ImmunoOncology Company. All rights reserved.